Menu
Currency
GWAS Study

Assessment of Novel Genome-Wide Significant Gene Loci and Lesion Growth in Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Grassmann F, Harsch S, Brandl C et al.

31120506 PubMed ID
GWAS Study Type
935 Participants
49 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GF
Grassmann F
HS
Harsch S
BC
Brandl C
KC
Kiel C
NP
Nürnberg P
TM
Toliat MR
FM
Fleckenstein M
PM
Pfau M
SS
Schmitz-Valckenberg S
HF
Holz FG
CE
Chew EY
SA
Swaroop A
RR
Ratnapriya R
KM
Klein ML
MZ
Mulyukov Z
ZP
Zamiri P
WB
Weber BHF
Chapter II

Abstract

Summary of the research findings

Importance: Age-related macular degeneration (AMD) is a common threat to vision loss in individuals older than 50 years. While neovascular complications in AMD are treatable, there is currently no therapy for geographic atrophy secondary to AMD. Geographic atrophy lesion progression over time shows considerable interindividual variability, but little is known about prognostic factors.

935 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

935
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Germany
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.